Cempra (CEMP) kicked off its morning with positive news that sent its stock soaring ahead of market's open. 

The Chapel Hill, N.C.-based biotech announced top line results from a phase three clinical trial of its fusidic acid, which can be used to treat skin infections Friday morning. The company's stock was up 46% ahead of the opening bell on the news, hitting $4.65 per share. This, though, was not enough for shares to regain the loss of 82% of their value experienced in the past year. 

Incyte (INCY) , meanwhile, was up 5% pre-market thanks to news that it will join the S&P 500, replacing Spectra Energy Corp. (SE) . Incyte shares hit $128.10 apiece ahead of the opening bell Friday. The company has seen a 63% boost to share price over the past year. 

Achillion Pharmaceuticals (ACHN) , meanwhile, was plummeting after reporting a loss for its fourth quarter after market's close Thursday. The company reported a loss of $4.4 million, or 3 cents per share. These results, though, beat the street's expectations of a loss of 18 cents per share. Investors, though, were still dumping the stock Friday ahead of market's open. Achillion shares fell 5.66% Friday, hitting $4 per share. This year, the company has lost 36% of its market value. 

Inovio (INO) , meanwhile, continued to climb ahead of market's open Friday. The company had a positive day Thursday, finishing up 4.5% after reporting positive clinical data on its Zika vaccine. Inovio continued to climb Friday ahead of the opening bell. Shares were up 2.03% ahead of market's open, hitting $7.04 apiece. 

More from Stocks

A Hungry Grizzly Bear Is Stalking the Stock Market

A Hungry Grizzly Bear Is Stalking the Stock Market

Tesla Has Lost 15% Since Musk's Take-Private Tweet

Tesla Has Lost 15% Since Musk's Take-Private Tweet

Why Most Americans Like a Volatile Stock Market: Study

Why Most Americans Like a Volatile Stock Market: Study

Should Retirees Invest in the Tech Sector?

Should Retirees Invest in the Tech Sector?

Here's How to Trade Walmart, Nordstrom, Macy's and J.C. Penney After Earnings

Here's How to Trade Walmart, Nordstrom, Macy's and J.C. Penney After Earnings